An emerging body of evidence suggests that the changing global climate is already affecting infectious disease transmission patterns. As noted today in a symposium at the 58th annual meeting of the American Society of Tropical Medicine and Hygiene (ASTMH), such changes are expected to have a profound impact on global public health. [More]

Experts at an American Society of Tropical Medicine and Hygiene meeting this week said that resistance to the best available drug to treat malaria "is more widespread in Southeast Asia than previously reported," Science News/Wired Science reports. Researchers have been monitoring drug resistance along the Thailand-Cambodia border where patients taking artemisinin combination therapy - the most potent treatment for malaria - have been clearing the parasite from their bodies more slowly. [More]

Discus Dental®, LLC today announced the release of its newly redesigned Zoom® Chairside Whitening Kit, improving overall procedure ease of use and safety by reducing the total number of steps in the Zoom procedure. [More]

Immunization with either live attenuated influenza vaccine (LAIV, also known as FluMist®), or trivalent inactivated influenza vaccine (TIV), appears to offer a protection (~ 45%) against the novel A/H1N1 virus, the cause of the present influenza pandemic. However, the benefit was largely attributed to the youngest age group. The finding emerges from an evaluation of medical encounters and seasonal influenza immunization of U.S. military service members. [More]

On November 19, 2009, the kick-off meeting for the Euregio-project "EurSafety Health-net" has taken place. EurSafety Health-net is the follow-up of EUREGIO MRSA-net, that, according to the Robert Koch Institute, gained some sort of model character all over the nation when talking about prevention of hospital acquired MRSA infection. Besides the protection against infection, the main goal of this new project is to strengthen the patients' safety on both sides of the border. [More]

Evidence of resistance to the antimalarial drug artemisinin and its derivatives threatens efforts to control malaria in Southeast Asia, and experts fear artemisinin resistance may spread from the Thailand-Cambodia border to affect other malaria endemic countries. Evidence to such effect was presented today at the 58th annual meeting of the American Society of Tropical Medicine and Hygiene (ASTMH). [More]

ScinoPharm, a leading global supplier of active pharmaceutical ingredients (APIs), announced that its Tainan facility has received the Potent Compound Safety Certification from SafeBridge(R) Consultants, Inc. [More]

In light of World Toilet Day Thursday, several news outlets examine the impact of poor sanitation on health. [More]

SAFEBRIDGE® CONSULTANTS, INC., headquartered in Mountain View, California, has announced that ScinoPharm Taiwan Limited in Tainan, Taiwan has met the criteria established under the SafeBridge program for “Potent Compound Safety Certification” and has been deemed competent and proficient in the safe handling of potent active pharmaceutical ingredients (“APIs”). [More]

Indoor smoking bans have forced smokers at bars and restaurants onto outdoor patios, but a new University of Georgia study in collaboration with the Centers for Disease Control and Prevention suggests that these outdoor smoking areas might be creating a new health hazard. [More]

While efforts to control and eliminate malaria have made great strides during the past five years, the looming specter of drug resistance heightens the importance of continued research and development for new tools to assure continued success, according to malaria scientists and public health experts appearing today on Capitol Hill. [More]

Today, Merz Pharmaceuticals announced Xeomin®, the first botulinum toxin type A free from complexing proteins has been granted an extension of indication for post-stroke spasticity of the upper limb presenting with flexed wrist and clenched fist in adults in various European countries. [More]

The American Society of Tropical Medicine and Hygiene (ASTMH) today honored TIME Magazine Foreign Correspondent Vivienne Walt with its Communications Award during the opening ceremony of its 58th annual meeting. [More]

The National Committee for Quality Assurance (NCQA) today announced plans to revise its landmark evaluation of medical practices through the Physician Practice Connections®-Patient-Centered Medical Home™ (PPC®-PCMH™) to reflect the growing interest in this promising approach to improving care quality. [More]

Researchers at the University of Pittsburgh and the University of Iowa will lead a $9 million, five-year initiative to study the cause of facial birth defects. The FaceBase Consortium will create an encyclopedic database of how the faces of children develop and what goes wrong to cause malformations. [More]